Stimulation-based assays have the potential to provide greater sensitivity, with α-synuclein peptide exposure shown to elicit increased TNF secretion in lymphocytes from PD patients but not from neurologically healthy controls (NHCs)26. The gene discussed is TNF; the disease is Parkinson disease.